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Abstract
Background: The impact of sex on cardiac morphology and function in chronic volume overload has been described
in detail. However, the relation between sex and contractile properties at the actin-myosin level has not been well
defined. Therefore, we evaluated the influence of sex on the contractile capacities of patients with chronic volume
overload.
Methods: In 36 patients (18 males, 65 ± 9 years; 18 females, 65 ± 13 years) scheduled for elective mitral valve surgery
due to severe mitral regurgitation (MR) with preserved left ventricular function, right auricle samples were obtained
prior to extracorporal circulation. The fibers were prepared and skinned and exposed to a gradual increase in the
calcium concentration (from pCa of 6.5–4.0) for calcium-induced force-developing measurements. Calcium sensitivity
was also measured and recorded.
Results: The pCa-force relationship of the fibers obtained from males and females was significantly different, with
the force values of the female fibers greater than those of male fibers at maximum calcium concentrations (pCa
of 4.0: 3.6 ± 0.3 mN versus 3.2 ± 0.4 mN, p 0.02) and pCa of 4.5 2.6 ± 0.6 versus 2.0 ± 0.5, p 0.002). In contrast, the
force values of female fibers were lower at mean calcium concentrations compared to those of male fibers (at 5.5
and pCa of 6.0: 1.0 ± 0.3 mN versus 1.2 ± 0.5 mN, p 0.04; 0.61 ± 0.05 versus 0.88 ± 0.09, p 0.04).
Calcium sensitivity was observed at pCa of 5.0 in females and pCa of 4.5 in males.
Conclusion: This study demonstrated that female fibers from patients exposed to chronic volume overload developed
higher force values at a given calcium concentration compared to fibers from male patients. We assume that female
patients might tap the full force potential, which is required when exposed to the highest calcium concentrations in
our experimental cycle. The calcium sensitivity among genders was significantly different, with the results suggesting
that males have higher calcium sensitivity and might compensate for lower force values at maximal calcium
concentrations by a higher affinity for calcium. Hence, female patients with MR seem to work more “energy efficient”.
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Background
Chronic volume overload leads to various adaption
mechanisms, such as increased ventricular mass and
end-diastolic volume [1]. Several studies of rodents have
shown that chronic volume overload led to extensive
hypertrophy and marked dilatation in male rats but not
in female rats [2]. Furthermore, female rats exposed to
chronic volume overload did not exhibit adverse
ventricular remodeling and showed reduced mortality
compared to male rats [3]. Thus, classical signs of heart
failure are missing in female rats with induced volume
overload. In humans, chronic mitral regurgitation (MR)
caused left ventricular dilation, a study showed that the
end-diastolic dimensions increased, whereas chronic MR
led to eccentric hypertrophy [4].
Calcium plays a major role in the cardiac contraction
cycle. Evidence has long existed for sex differences in
intrinsic cardiac contractile properties [5], positive ino-
tropic responses to Ca2+ [6], Ca2+ channels in the heart
[7], and hormone responsiveness [5, 8]. In accordance
with these results, recent studies suggested that sex
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hormones may attenuate remodeling processes in
chronic volume overload and that sex may influence the
development of cardiac pathologies in chronic volume
overload [2, 3, 9–12]. It is not known whether this path-
ology affects contractile properties at the level of the
contractile apparatus or whether the influence of sex
hormones differs between males and female patients.
However, some recent animal studies reported that sex
influenced ventricular remodeling induced by chronic
volume overload [5, 6]. For example, Gardner and co-
workers concluded that male rats with induced volume
overload developed significant dilatation of left ventricles
after 8 weeks, whereas female rats did not [2, 3]. Thus,
classical signs of heart failure are missing in female rats
with induced volume overload. These data were sup-
ported by Dent and coworkers, who showed that volume
overload in mice led to a greater increase in cardiac
muscle mass and wall thickness than in female mice,
without any changes in the ventricular diameter, whereas
the ventricular dimensions increased and left ventricular
end-diastolic pressure in male mice [11, 12]. This dem-
onstrates that sex modifies ventricular remodeling in ro-
dents exposed to volume overload.
There are limited data in the literature on sex differ-
ences in the effect of chronic volume overload on con-
tractility in humans with severe MR. Therefore, the aim
of the present study was to evaluate the impact of
chronic volume overload on the contractility of right
auricle tissue of female and male patients scheduled for
elective mitral valve surgery.
Methods
The ethics committee of the Medical Association of
Rheinhessen approved this study. The experiments
were carried out in the experimental laboratory of the
Department of Cardiothoracic and Vascular Surgery of
the University Hospital of Mainz.
All the patients were informed and gave written con-
sent for the use of intraoperative resected tissue in fur-
ther research. All the experiments were carried out
according to the Declaration of Helsinki.
Eighteen female and 18 male patients with pure severe
mitral valve insufficiency who were scheduled for elect-
ive mitral valve surgery were included in the study. The
exclusion criteria were aged <18 years, emergency sur-
gery, atrial fibrillation, primary pulmonary hypertension,
other valve lesions, coronary artery disease, an Ejection
Fraction of <50 %, and endocarditis.
Echocardiographic data were obtained preoperatively
from echocardiographic examinations performed in our
hospital. We defined left atrial dilatation as >38 mm ap
(in females) and >40 mm ap in males and left ventricular
dilatation (m-mode measurements) as >53 mm (in fe-
males) and >59 mm (in males). Dilatation of the mitral
annulus was defined for males/females in end-systolic
apical four-chamber view more than 3.8 cm/3.3 cm
(end-diastolic apical four-chamber view more than
4.1 cm/3.6 cm) [12].
Skinned fiber preparation
Right auricle tissue was taken from the 36 patients prior
to implementation of extracorporal circulation and pre-
pared for skinned fiber experiments. The process of
skinned fiber preparation has been described in detail
elsewhere [8–10]. Briefly, the fibers were collected in the
operating theater after resecting the right auricle. Using
the no-touch-technique, the auricular tissue was trans-
ferred to an ice-cooled vial (4 °C) filled with an oxygen-
ated cardioplegic solution (1000 ml of Krebs-Henseleit
solution in mmol/L of 118.07 NaCl, 11.1 C6H12O6 +
H2O, 4.7 KCK, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4 + 7
H2O, and 1.8 CaCl2 + 2H2O). From this solution, 100 ml
were removed and 30 mmol/L of an ATP-sensitive potas-
sium canal inhibitor, C4H2NO2 (2,3-butanedione mono-
xime), were added. The auricular was then placed in a dish
filled with 20 ml of a preparation solution (4 °C) (amounts
in mM: C3H4N2 68.08, NaN3 65.01, C14H24N2O10 380.4,
C4H10O2S2.154.3, MgCl2 × 6 H2O 203.3, C10H14N5O13 P3
Na2 605.2). Subsequently, the muscle bundles were resected
from the auricle and placed in a test tube containing
9900 μl of the preparation solution, including 1 % Triton-
X-100 (100 μl), for 24 h at 4 °C on a shaking device. The fi-
bers were skinned after being rolled for 24 h on a special
rotation device to remove membrane-dependent properties
[9]. Following this procedure. the fiber bundles were pre-
pared for the experimental setup.
The experimental setup consisted of a specially designed
“gradient measurement device,” in which the concen-
tration inside the perfusion chamber was automatically
increased stepwise during the experiment (Scientific In-
struments, Heidelberg, Germany). The device consists of
two pumps, which transports and withdraws a specific
amount of the solution in and out of a perfusion chamber.
In this perfusion chamber, the skinned fiber was fixed be-
tween two forceps and immersed in the solution. As the
calcium-containing solution was transported to the perfu-
sion chamber, the concentration was increased in a step-
wise manner. When the skinned fiber started to contract,
the resulting force-development curve was recorded by
the attached computer system. Of course, to achieve a
special calcium concentration, which is calculated by the
attached computer system, several parameters (the con-
centration of EGTA, free calcium concentration, tubing
volume, volume of the perfusion chamber etc.) have to be
entered in the computer system before starting the experi-
ments. Thus, the concentration of calcium can be calcu-
lated precisely (Gradient Program, Scientific Instruments,
Heidelberg).
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For the experimental set-up, the fibers were cut in strips
of 2–2.5 mm× 0.3 mm and fixed between two forceps in a
cuvette, which served as a perfusion chamber. To achieve
steady state conditions, the cuvette was perfused with a
relaxation solution (contents in mM: C3H4N2 68.08,
C4H8N3O5PNa2 + 4 H2O 327.2, NaN3 65.01, C14H24N2O10
380.4, MgCl2 203.3, C4H10O2S2.154.2, and C10H14N5O13 P3
Na2 605.2) and 400 U/ml of creatine kinase (Boehringer,
Mannheim, FRG). To induce contraction, solution calcium
and CaCl2 (147.02 mM) were added. The free calcium con-
centration was obtained by mixing the relaxation and con-
traction solution in appropriate proportions. The desired
calcium concentrations were calculated by a computer pro-
gram (Scientific Instruments, Heidelberg, Germany), fol-
lowing the equation of Fabiato and Fabiato and given as
pCa (−log of free [Ca]+) until steady state conditions were
observed. Afterwards, the fibers were carefully prestretched
to 20 mg to achieve optimal overlapping of contractile
elements (according to a cardiomyocyte sarcomere length
of 2 μm). After achieving a steady state, the fibers were
exposed to the contraction solution. A computer program
calculated the desired calcium concentrations (i.e., pCa 6.5
until 4.0) (Scientific Instruments Heidelberg, Germany).
The fibers were exposed to a continuous increase in
the calcium concentration, starting at pCa 6.5 (lowest
calcium concentration) and ending at pCa 4.0 (highest
calcium concentration). The rising calcium concentra-
tion and responding force development were simultan-
eously recorded and sampled on the attached computer.
Three fibers from each patient were exposed to cycles of
increasing calcium concentrations. Thus, the final ana-
lysis consisted of 54 data sets for female fibers and 54
data sets for male fibers.
Statistical analysis
The statistical analysis was performed using SPSS soft-
ware 13.0 for PC (Analytical Software, Chicago, IL,
USA). Values are expressed as the mean ± S.D, and
numbers of patients are expressed as percentages. The
Shapiro–Wilk test was used to verify normal statistical
distributions. The Welch test was used to evaluate sta-
tistically significant differences between males and fe-
males in RAP, wedge, LVESV, height, weight, and BMI.
The Wilcoxon rank-sum test was used to verify statisti-
cally significant differences in the force values of pCa
6.5–4.0, TAPSE, age, and EF. A Chi square test was
used to evaluate differences in the prevalence of the
dilatation of the mitral valve ring, LA and LV dilatation,
and grade of TR and MR. Statistical significance was
determined using an alpha level of < 0.05.
Results
The force values of skinned fibers from females were
higher than those of male fibers at the highest calcium
concentration (pCa of 4.0: 3.6 ± 0.3 mN versus 3.2 ± 0.4
mN, p 0.02; pCa of 4.5 2.6 ± 0.6 versus 2.0 ± 0.5, p 0.002)
and lower than those of male fibers at mean calcium con-
centrations (pCa of 5.5 and pCa of 6.0: 1.0 ± 0.3 mN
versus 1.2 ± 0.5 mN, p 0.04; 0.61 ± 0.05 versus 0.88 ± 0.09,
p 0.04, see Fig. 1). At mean steps of calcium concentra-
tions (pCa 5.0), the differences subsided (females 1.6 ± 0.5
mN versus 1.63 ± 0.9, p 0.1).
Calcium sensitivity, given as the calcium concentration
at which the half maximal concentration was achieved,
occurred at pCa 5.0 in males and 4.5 in females. Hence,
the males were more sensitive to calcium than females
(p 0.03, Tables 1 and 2).
Comparing the clinical data, we observed that dilata-
tion of the mitral valve annulus occurred significantly
more often in the female group (55 versus 15 %, p 0.01).
There was no significant sex difference in the prevalence
of left atrial dilation and left ventricular dilatation. Fe-
male gender differed significantly in the end-diastolic
septum thickness (11 mm versus 15 mm, p 0.04), which
was smaller in female gender. Additionally, the females
were significantly shorter than the males (164 ± 8 versus
174 ± 9, p 0.003). However, the BMI of the two groups
was similar. The RAP (6.8 ± 2.2 versus 9.5 ± 2.7, p 0.003)
was significantly lower in females than males (25.5 ± 4
versus 19 ± 7, p 0.001, Table 3). The wedge pressure
(25.5 ± 4 mmHg versus 19 ± 7 mmHg, p 0.001) and
mean pulmonary artery pressure (PAP) (45 ± 20 mmHg
versus 36 ± 9 mmHg, n.s.) were higher in females than
in males. In addition, the TAPSE (21.3 ± 3.7 versus
19.3 ± 4.2, n.s.) was elevated, and LVEF (43.9 ± 11.5
versus 51.3 ± 11.8, p 0.04) was slightly decreased.
Discussion
In this study, we observed sex differences in the con-
tractile performance of patients with severe MR. Skinned
fibers from females achieved more force at higher supra-
normal calcium concentrations (pCa of 4.0 and pCa of
4.5). In contrast, male fibers developed higher forces at
lower calcium concentrations (pCa of 5.0–6.5), which
Fig. 1 Comparison of female and male pCa force development in
patients with volume overload
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included the “physiological concentration” at pCa of
5.0–6.0. The calcium sensitivity of the male and female
fibers was similar. We propose that females save force
capacities, which can be mobilized at higher force
values, whereas males tap the full force capacity at
physiological concentrations of pCa of 5.0 and 6.0. How-
ever, it is unclear how female fibers could develop
increased contractibility at higher calcium concentra-
tions. Thus, it is uncertain whether force fatigue. On
the other hand, clinical signs, such as wedge pressure,
mean PAP, TAPSE, and LVEF might give some evidence
for a reduced biventricular function, which was ob-
served in females, compared to males. Although there
is controversy in the literature on the force values of
healthy male and female skinned fibers (i.e., whether
they are higher in females or males), all the previous
studies were performed in rats or other animal models
[1–3, 5–7, 9, 10].
In common with the findings of the present study,
Schwertz observed increased forces in female skinned
human rat atria at high extracellular calcium in the pres-
ence of tetanic contraction and greater force and a
higher maximal rate of contraction in females compared
to males [8]. Another study also reported that the cal-
cium sensitivity of female rats seemed to be higher than
that of male rats [6].
In the presence of volume overload, Dent found sex-
specific differences: Females developed greater increase
in cardiac mass, but the rates of pressure development
(+dP/dt) and decay (−dP/dt) were depressed and left
ventricular end-diastolic pressure increased in male rats
at 16 weeks post-AV shunt. Decreased LV internal
diameters, as well as depressed fractional shortening, oc-
curred in males, whereas increases in posterior wall
thickness were seen in female rats at 16 weeks post-AV
shunt [11, 12]. Therefore, sex-specific remodeling pro-
cesses seem to occur, at least in rodents. In the present
study, the pressure values (wedge and PAP) of females
increased more often than those of males, but they had
decreased RAP values. Furthermore, the LVEF was
slightly reduced in females compared to males. Thus,
the observations are somewhat similar to those reported
Table 1 Summary of clinical data of the patients
Gender Female Male
Number 18 18
Age (years) 65 ± 9 65 ± 13
Height (cm) 164 ± 8 174 ± 9
Weight (kg) 69 ± 12 76 ± 13
BMI 25 ± 5 25 ± 3
Left Atrium Dilatation (number of patients) 7 (35 %) 9 (45 %)
Left Ventricle Dilatation (number of patients) 4 (20 %) 4 (20 %)
Mitral Valve Annulus Dilatation (number of
patients)
3 (15 %) 11 (55 %)
Prolapse of Mitral Valve 10 (50 %) 9 (45 %)
Ejection Fraction (%) 46 ± 11 54 ± 11
Mean grade of MR 3.4 ± 1.1 4 ± 0.3
Enddiastolic Septum thickness (mm) 15 ± 5 mm 11 ± 4.1 mm
Mean PCWP (mmHg) 25.5 ± 4 19 ± 7
Mean mPAP (mmHg) 45 ± 20 36 ± 9
Mean RAP (mmHg) 6.8 ± 2.2 9.5 ± 2.7
TAPSE 21.3 ± 3.7 19.3 ± 4.2
LVESV (ml) 43.9 ± 11.5 51.3 ± 11.8
Grade of TR 1 ± 0.2 1 ± 0.1
Table 2 Summary of pCa-force values
Male patients Female patients p
pCa 4.0 3.2 ± 0.4 mN 3.6 ± 0.3 mN 0.02
pCa 4.5 2.0 ± 0.5 mN 2.6 ± 0.6 mN 0.002
pCa 5.0 1.63 ± 0.9 mN 1.6 ± 0.5 mN 0.1
pCa 5.5 1.2 ± 0.5 mN 1.0 ± 0.3 mN 0.04
pCa 6.0 0.88 ± 0.09 mN 0.61 ± 0.05 mN 0.04
pCa 6.5 0.51 ± 0.1 mN 0.32 ± 0.3 mN 0.1
pCa++50 5.0 4.5 0.03
Table 3 Summary of the results
Gender Female Male p
Number 18 18
Age (years) 65 ± 9 65 ± 13 n.s
Height (cm) 164 ± 8 174 ± 9 0.003
Weight (kg) 69 ± 12 76 ± 13 n.s
BMI 25 ± 5 25 ± 3 n.s
Left Atrium Dilatation (number of
patients)
9 (50 %) 7 (38 %) n.s
Left Ventricle Dilatation (number of
patients)
4 (22 %) 8 (44 %) n.s
Mitral Valve Annulus Dilatation
(number of patients)
3 (16 %) 11 (61 %) 0.01
Prolapse of Mitral Valve 10 (55 %) 9 (50 %) n.s
Ejection Fraction (%) 46 ± 11 54 ± 11 n.s
Mean grade of MR 3.4 ± 1.1 4 ± 0.3 n.s
Enddiastolic Septum thickness (mm) 15 ± 5 mm 11 ± 4.1 mm 0.04
Mean PCWP (mmHg) 25.5 ± 4 19 ± 7 0.001
Mean mPAP (mmHg) 45 ± 20 36 ± 9 n.s
Mean RAP (mmHg) 6.8 ± 2.2 9.5 ± 2.7 0.003
TAPSE 21.3 ± 3.7 19.3 ± 4.2 n.s.
LVESV (ml) 43.9 ± 11.5 51.3 ± 11.8 0.04
Grade of TR 1 ± 0.2 1 ± 0.1 0.5
Bening et al. BMC Cardiovascular Disorders  (2016) 16:197 Page 4 of 6
by Dent. Calcium sensitivity was different among gen-
ders, males needed less calcium to achieve half maximal
activation. This means, they are more sensitive to cal-
cium compared to females. Wattanapermpool and co-
workers presented similar results, with a loss of estrogen
by ovariectomy increasing the sensitivity of rats to cal-
cium [13]. Their results are in accordance with the find-
ings in the present study of reduced calcium sensitivity
in fibers obtained from female patients.
According to the difference in cardiac properties, we
observed gender-related differences in the clinical pic-
ture of mitral valve regurgitation scheduled for elective
mitral valve surgery due to MR. We observed more mitral
annulus dilatation in females but no significantly higher
incidence of prolapse, flail leaflet, or chorda rupture in
one of the groups. However, prolapse and LA dilatation
were more common in the female group. These findings
are accordance with those in the literature [14].
In the present study, although there were no differ-
ences in the preoperative clinical presentation in terms
of pathological findings in the mitral valve, sex-specific
cardiac remodeling can be assumed, as female patients
present more frequently with left atrial dilatation, and
male patients present more often with left ventricular
dilatation. However, this was not significant, but might
be an explanation for reduced force capacity at the level
of the atria because right heart function parameters,
such as TAPSE, were also slightly increased in females.
In the literature, there are only a few studies on the sex-
specific clinical presentation in humans with severe MR.
Several animal studies have provided evidence for dif-
ferences in the remodeling process. Janicki et al. de-
scribed a sex-specific remodeling process in a rodent
model of induced volume overload [15]. In their study,
female rodent hearts showed less chamber dilatation but
more ventricular hypertrophy than male hearts, which
showed significant dilatation and wall thinning [15]. An-
other rodent study demonstrated that the female heart
was cardioprotected, developed concentric hypertrophy,
and remained compensated [16]. The idea of sex-specific
remodeling processes extends to the cellular level. Stud-
ies reported an increase in the cardiomyocyte cross-
sectional area (parallel sarcomeres) and length (in-series
sarcomeres) after volume overload in female rats but no
such increases in male rats [17, 18]. This might explain
the possibility of females to recruit further force when ex-
posed to even higher calcium concentrations. Further
studies should be conducted to determine whether such a
compensatory mechanism exists and its clinical relevance.
In our opinion, these findings could have clinical rele-
vance for on the timing of interventions in patients pre-
senting with severe mitral valve regurgitation. To date,
the guidelines on surgical treatment for asymptomatic
severe MI have relied solely on the level of LV dilatation,
end-systolic diameter, EF, and presence of atrial fibrilla-
tion and/or pulmonary hypertension [19]. If we assume
the existence of a sex-specific remodeling process, it is
possible that female patients are referred too late for mi-
tral valve surgery because the first response to overload
in females is ventricular hypertrophy and an increase in
LV mass rather than ventricular dilatation. The afore-
mentioned hypothesis is supported by data from the lit-
erature showing that the short- and long-term survival
of females who undergo surgery for MR is worse than
that of male patients [20].
Limitations of the study
The advantage of the preparation used in the present
study is the independency of membrane-dependent pro-
cesses, as pharmacological influences (pre- and periopera-
tive medications) can be excluded due to the wash-out
process [9]. Nevertheless, this study has some limitations.
First, the duration of asymptomatic MR may have influ-
enced the results, as we do had no data on the duration of
presurgical treatment for MR. Although the potential ef-
fect of pharmacological treatment can be likely excluded
by the “skinning fiber model”, Wankerl showed that an
effect of various kinds of cardiac disease (independent
of the disease duration) could solely be shown in hu-
man atrial tissue, since in ventricular tissue differences
in cardiac sensitivity are no more existent [6]. Second,
the mechanism of skinning, as well as demembranizing
the fibers, could have influenced the contractile ability
of the fibers and influenced the results. Third, a selec-
tion bias could have influenced the data due to the
small sample size.
Conclusions
These preliminary data suggest that female patients are
better able than males to tolerate volume overload, as
higher force values were recorded. The force capacity of
male fibers significantly reduced. The reduction in the
force capacity could be due to various factors, such as a
sex-specific response to volume overload, global cardio-
myocyte remodeling due to volume overload, or changes
in calcium handling. The apparent ability of females to
tolerate volume overload are in accordance with the
clinical picture of late diagnosis and treatment of female
patients presenting with severe MR.
The existing sex-specific differences in postoperative
outcomes, in addition to our experimental findings,
seem to justify a re-evaluation of the management of mi-
tral valve disease in female patients. Further studies with
a larger number of patients are needed to support these
observations and to elucidate the clinical relevance of
these results.
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